Ionis to hold olezarsen Phase 3 data webcast
Ionis to hold olezarsen Phase 3 data webcast |
[28-March-2024] |
Webcast scheduled for Monday, April 8 at 10:00 a.m. Eastern Time CARLSBAD, Calif., March 28, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Monday, April 8th at 10:00 a.m. Eastern Time to discuss the olezarsen Phase 3 Balance study results in patients with familial chylomicronemia syndrome (FCS) presented at the 2024 American College of Cardiology Annual Meeting. The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address. About Ionis Pharmaceuticals, Inc. View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-olezarsen-phase-3-data-webcast-302101842.html SOURCE Ionis Pharmaceuticals, Inc. | ||
Company Codes: NASDAQ-NMS:IONS |